Nathalie Méneveau

Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis

Elsa Curtit, Virginie Nerich, Laura Mansi et al. · The Oncologist · 2013 · 96 citations · Full text

Medicine, Endocrinology, Oncology +17

A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study

Quentin Jacquinot, Nathalie Méneveau, Marion Chatot et al. · BMC Cancer · 2017 · 33 citations · Full text

Medicine, Cardiology, Oncology +17

Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice

Guillaume Mouillet, Antoine Falcoz, J. Fritzsch et al. · Quality of Life Research · 2021 · 28 citations

Pharmacy, Health Informatics, Oncology +17

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

Quentin Jacquinot, Nathalie Méneveau, Antoine Falcoz et al. · Frontiers in Cardiovascular Medicine · 2022 · 26 citations · Full text

Medicine, Cardiology, Breast Oncology +16

Ventilatory Thresholds Determined from HRV: Comparison of 2 Methods in Obese Adolescents

Sylvain Quinart, Laurent Mourot, Véronique Nègre et al. · International Journal of Sports Medicine · 2013 · 19 citations

Life Sciences, Health Sciences, Physiology +8